Skip to main navigation Skip to search Skip to main content

Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies

  • Alison C. Mackinnon
  • , Uzma Tufail-hanif
  • , Mark Wheatley
  • , Adriano G. Rossi
  • , Christopher Haslett
  • , Michael Seckl
  • , Tariq Sethi

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)36-47
JournalBritish Journal of Pharmacology
Volume156
Issue number1
DOIs
Publication statusPublished - 1 Jan 2009

Cite this